000 | 01950 a2200493 4500 | ||
---|---|---|---|
005 | 20250514204209.0 | ||
264 | 0 | _c20041221 | |
008 | 200412s 0 0 eng d | ||
022 | _a0014-2980 | ||
024 | 7 |
_a10.1002/eji.200424981 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGomez-Bougie, Patricia | |
245 | 0 | 0 |
_aThe imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells. _h[electronic resource] |
260 |
_bEuropean journal of immunology _cNov 2004 |
||
300 |
_a3156-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xphysiology |
650 | 0 | 4 | _aApoptosis Regulatory Proteins |
650 | 0 | 4 | _aBcl-2-Like Protein 11 |
650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Survival _xphysiology |
650 | 0 | 4 |
_aCycloheximide _xpharmacology |
650 | 0 | 4 |
_aDactinomycin _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _ximmunology |
650 | 0 | 4 | _aJanus Kinase 2 |
650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aMultiple Myeloma _ximmunology |
650 | 0 | 4 | _aMyeloid Cell Leukemia Sequence 1 Protein |
650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aProtein Isoforms |
650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aTranscription, Genetic _ximmunology |
650 | 0 | 4 |
_aTyrphostins _xpharmacology |
700 | 1 | _aBataille, Régis | |
700 | 1 | _aAmiot, Martine | |
773 | 0 |
_tEuropean journal of immunology _gvol. 34 _gno. 11 _gp. 3156-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/eji.200424981 _zAvailable from publisher's website |
999 |
_c15151910 _d15151910 |